IS THE SOLUTION
Relivra is a breakthrough pain relief formula which has demonstrated dramatic decrease in pain in 3 human clinical trials conducted at Mt.Sinai Hospital, New York.
The advanced terpenoid-flavonoid Naringin peptide impregnated sol-gel formulation, Relivra conveys wound healing and pain reliving effect via down-regulation of inflammatory oxidant molecular factors and up-regulation of protective cell signaling without diffusion to breast milk. Additionally, effective delivery of protective and pro-regeneration molecules induces angiogenesis and tissue regeneration.
In confronting the global dilemma of pain – a complex and pervasive health issue – Relivra® emerges as a transformative force and a comprehensive solution. Developed through rigorous research and innovative technology, Relivra®, the flagship product of Relivenol® - a multi-applicaion platform, is a testament to the synergy of cutting-edge science and patient-centric care. Its precise targeting mechanism allows for efficacious treatment of both identifiable and elusive pain conditions, marking a significant advancement in the field. Relivra®'s affordability and accessibility underscore its commitment to alleviating the global burden of pain, fostering a more equitable healthcare landscape that transcends socio-economic and racial barriers.
Market Potential
Pain is a global health problem, with an estimated 1 in 5 adults suffering from pain and another 1 in 10 adults diagnosed with chronic pain each year. Pain affects all populations, but is not distributed equally across the globe and socio-economic spectrum. Relivra® is an inexpensive,non-addictive solution ready to be deployed on a global scale. Relivra® is generally able to get to the source of pain, giving it a tremendous edge over existing formulations. As a company, we are focused on conquering pain, a critical unmet global need.
Relivra® Formula
Relivra® is unique in a few aspects. We introduced proprietary NN-26/65 formulation into Relivra® to increase stabilizing and anti-oxidative properties of skin pain treatment. Additionally, we use certain preparatory methods in Relivra® production process to reduce and control oxidation. The ingredients used in Relivra® formulation are vital in maintaining oxidative stability. NN-26/65, for example, may act as an antioxidant targeting underlying roots of prolonged trauma and preventing the development of chronic pain, while providing personalized efficiency based on ethnicity, gender, and age specifics. Advanced features of Relivra® formulation provide for superior biocompatibility, stability, site-specificity, prolonged action, and high drug-loading capability, while eliminating toxicity risks. We evaluate stability of Relivra® preparation using various biochemical and thermodynamic techniques. Careful attention to the preparation process and assessment of their oxidative stability will help produce safer emulsions without compromising efficacy.
Delivery System
Relivra® uses a customizable delivery system that allows safely delivering therapeutic agents at calculated rates to targeted tissue and reducing unwanted distribution. As a result, Relivra® system has improved pharmacokinetics, pharmacodynamics, and uptake of various therapeutic molecules. These improvements are due to reduced binding and interaction of the incorporated molecule with endogenous molecules. Relivra® formula reduces premature enzymatic degradation via protection conferred by the carrier system to the multi-component carrier molecule before it reaches the targeted site. This leads to Relivra® enhanced penetration, increased solubility, improved bioavailability, and superior analgesic capacity.
Competitive Landscape
Relivra® is a first known formula on the topical pain-treatment market using advanced physicochemical features and customizable carrier. Relivra® provides absorption and penetration of its active moieties within epidermal layers in a remarkable way of achieving selectable burst or sustained release. Advanced features of Relivra® formulation provide for superior biocompatibility, stability,
site-specificity, prolonged action, and high
drug-loading capability, while eliminating toxicity risks. Relivra® is unique in that it uses natural NN-26/65 to increase stabilizing and anti-oxidative properties of skin pain treatment. Relivra® also uses certain preparatory methods in the production process to reduce and control oxidation.
Market Overview
The topical pain-relieving industry has boomed in recent years and is expected to continue growing at a CAGR of 6.21% from 2023 to 2028. The market is driven by increasing prevalence of chronic pain, rising geriatric population, and growing demand for cost-effective pain management. Relivra® is a unique pain relief formula that has demonstrated a dramatic decrease in pain in clinical trials, making it ideal for people suffering from chronic pain. Relivra® is targeted towards people suffering from pain, inflammation, and tissue damage due to injury or disease. According to the World Health Organization, 1 in 5 adults suffer from pain, and another 1 in 10 adults are diagnosed with chronic pain each year. Relivra®'s breakthrough formula is a non-addictive, inexpensive solution that is ready to be deployed on a global scale.
Conclusion
Relivra® is a groundbreaking product that has the potential to revolutionize the pain management industry. Our innovative formula, delivery system, and clinical trials make Relivra® a promising investment opportunity for investors who are looking for a high-potential biomedical startup. We are committed to expanding patient access to important, cost-effective pain relief medicine and delivering significant savings to the global healthcare system. We apply our scientific expertise and proprietary technologies to develop and commercialize a blockbuster pain relief product that is designed to make a meaningful difference in the way people manage their pain.
Relivra® is a novel topical advance pharmaceutical cream that treats pain, inflammation, and promotes tissue regeneration while promoting better blood circulation. With the growing concern for chronic pain and the need for cost-effective pain relief medicine, Relivra® has the potential to be a premier player in the topical pain-relieving industry.